Positive results from trial of Arecor’s insulin candidate AT247
Therapy demonstrates significantly accelerated insulin absorption and early exposure
Read More
Tag: insulin
Insulin glargine meets primary endpoint in Sanofi’s type 1 diabetes study
InRange is the first worldwide multicentre RCT to compare second generation basal insulins
Read More
FDA dismisses Jardiance for type I diabetes
The decision follows an FDA panel vote last November recommending against the approval of the drug.
Read More
Suliqua launches in UK
The approval is based on two phase III studies, LixiLan-O and LixiLan-L.
Read More
Fiasp approved for children in Europe
Novo Nordisk submitted label updates in March this year.
Read More
AZ’ Farxiga hit with complete response letter
AstraZeneca has said that it will work closely with the FDA to discuss the next steps.
Read More
NHS England scraps 7 more drugs on prescription
NHS England has discarded certain items as they are of “low clinical effectiveness”.
Read More
Positive results for Novo’s Xultophy
The insulin degludec and liraglutide combination helps patients achieve blood glucose targets.
Read More
Zynquista approved in EU for certain patients with type I diabetes
The approval is for adjunct use to insulin therapy to improve blood sugar control in adults.
Read More
EU approves AZ’ Forxiga for type I diabetes
The drug is the first oral medicine approved in Europe as an adjunct to insulin for adults with type I diabetes.
Read More
Novo Nordisk seeks label update for Fiasp in children
Novo Nordisk has submitted applications to both US and EU regulators for use of its fast-acting insulin Fiasp in children.
Read More
Novo buys UK group Ziylo
Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out based at Unit DX science incubator in Bristol, UK.
Read More
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
- NHS reduces long waits for cancer care and achieves faster ambulance responses
- MHRA’s AI Airlock to address challenges for regulating AI medical devices
